PHARMACEUTICAL BIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2024-04-28 ms8000001918173079 来自北京

请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2022-10-25 ms4000000216729917

麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂

37 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2023-06-25 耀眼的小光芒来自四川省

中药复方，有高效液相，动物实验。
12 January 2023
Submission Created
12 January 2023
Submission Incomplete
12 January 2023
Manuscript Submitted
12 January 2023
With Journal Administrator
16 January 2023
Submission Returned to Author
16 January 2023
Submission Incomplete
16 January 2023
Manuscript Resubmitted
16 January 2023
With Journal Administrator
19 June 2023
Submission Returned to Author
19 June 2023
Submission Incomplete
19 June 2023
Manuscript Resubmitted
19 June 2023
With Journal Administrator
PEER REVIEW
29 January 2023
With Editor
27 February 2023
Out for Review
19 March 2023
Revision Required
27 March 2023
Revision Incomplete
27 March 2023
Revised Manuscript Submitted
27 March 2023
With Journal Administrator
30 March 2023
With Editor
01 April 2023
Out for Review
23 April 2023
Revision Required
08 May 2023
Revision Incomplete
08 May 2023
Revised Manuscript Submitted
08 May 2023
With Journal Administrator
11 May 2023
With Editor
11 May 2023
Out for Review
27 May 2023
Decision Pending
09 June 2023
Revision Required
19 June 2023
Revision Incomplete
19 June 2023
Revised Manuscript Submitted
19 June 2023
With Journal Administrator
22 June 2023
With Editor
25 June 2023
Out for Review
25 June 2023
Decision Pending

38 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2023-05-10 ms7000002028471868 来自安徽省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：中药提取物
经验分享：期待投中
19 March 2023
With Editor
14 April 2023
Out for Review
20 April 2023
Revision Required
25 April 2023
Revision Incomplete
25 April 2023
Revised Manuscript Submitted
25 April 2023
With Journal Administrator
28 April 2023
With Editor
29 April 2023
Out for Review
01 May 2023
Revision Required
01 May 2023
Revision Incomplete
01 May 2023
Revised Manuscript Submitted
01 May 2023
With Journal Administrator
02 May 2023
With Editor
02 May 2023
Out for Review
04 May 2023
Decision Pending

90 20

展开20条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2022-04-22 Dr.Ding Jin

偏重的研究方向：中药复方
经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？

127 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2023-12-04 916603706 来自山东省

一年零一个月了。。。终于接收，历经无数次小修。

32 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2024-04-15 ms1000002137683196 来自湖南省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：成分鉴定;中药复方
经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了

5 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2024-03-08 ms8000001918173079 来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：药理实验;中药复方
经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！
先提前谢过心软的编辑和审稿人！
SUBMISSION
21 November 2023
Submission Created
24 November 2023
Submission Incomplete
24 November 2023
Manuscript Submitted
24 November 2023
With Journal Administrator
25 November 2023
Submission Returned to Author
01 December 2023
Submission Incomplete
01 December 2023
Manuscript Resubmitted
01 December 2023
With Journal Administrator
PEER REVIEW
09 December 2023
With Editor
11 January 2024
Out for Review
11 January 2024
Revision Required
20 January 2024
Revision Incomplete
20 January 2024
Revised Manuscript Submitted
20 January 2024
With Journal Administrator
23 January 2024
With Editor
24 January 2024
Out for Review
25 February 2024
Revision Required
28 February 2024
Revision Incomplete
28 February 2024
Revised Manuscript Submitted
28 February 2024
With Journal Administrator
29 February 2024
With Editor
01 March 2024
Out for Review

12 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2024-04-04 ms898308530249 来自四川省

审稿速度:12.0 | 投稿命中率:5.0
经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2200920, encodeId=4fc7220092075, content=请问，已经到Managing Edito修改文章结构和格式了，为何上传修改稿后，系统的状态重新变成了Out for Review，是又要进行一轮专家评审吗？又要重新找审稿人的意思吗？稿件由Associate Editor推荐给Managing Editor似乎被我们看成了一个通过专家评审的信号了，求解答！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Sun Apr 28 19:08:39 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2096101, encodeId=3d0f209610168, content=麻烦请教下各位大神请问小修之后out for review 是什么意思？又外审了吗？等待的感觉太痛苦了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73505396708, createdName=ms4000000216729917, createdTime=Tue Oct 25 19:32:44 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2144662, encodeId=f4d72144662dd, content=中药复方，有高效液相，动物实验。 12 January 2023 Submission Created 12 January 2023 Submission Incomplete 12 January 2023 Manuscript Submitted 12 January 2023 With Journal Administrator 16 January 2023 Submission Returned to Author 16 January 2023 Submission Incomplete 16 January 2023 Manuscript Resubmitted 16 January 2023 With Journal Administrator 19 June 2023 Submission Returned to Author 19 June 2023 Submission Incomplete 19 June 2023 Manuscript Resubmitted 19 June 2023 With Journal Administrator PEER REVIEW 29 January 2023 With Editor 27 February 2023 Out for Review 19 March 2023 Revision Required 27 March 2023 Revision Incomplete 27 March 2023 Revised Manuscript Submitted 27 March 2023 With Journal Administrator 30 March 2023 With Editor 01 April 2023 Out for Review 23 April 2023 Revision Required 08 May 2023 Revision Incomplete 08 May 2023 Revised Manuscript Submitted 08 May 2023 With Journal Administrator 11 May 2023 With Editor 11 May 2023 Out for Review 27 May 2023 Decision Pending 09 June 2023 Revision Required 19 June 2023 Revision Incomplete 19 June 2023 Revised Manuscript Submitted 19 June 2023 With Journal Administrator 22 June 2023 With Editor 25 June 2023 Out for Review 25 June 2023 Decision Pending, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937f5408133, createdName=耀眼的小光芒, createdTime=Sun Jun 25 15:29:31 CST 2023, time=2023-06-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2131395, encodeId=56382131395aa, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：中药提取物 经验分享：期待投中 19 March 2023 With Editor 14 April 2023 Out for Review 20 April 2023 Revision Required 25 April 2023 Revision Incomplete 25 April 2023 Revised Manuscript Submitted 25 April 2023 With Journal Administrator 28 April 2023 With Editor 29 April 2023 Out for Review 01 May 2023 Revision Required 01 May 2023 Revision Incomplete 01 May 2023 Revised Manuscript Submitted 01 May 2023 With Journal Administrator 02 May 2023 With Editor 02 May 2023 Out for Review 04 May 2023 Decision Pending , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b4a6472963, createdName=ms7000002028471868, createdTime=Wed May 10 13:31:27 CST 2023, time=2023-05-10, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1213454, encodeId=ad9c12134545e, content=偏重的研究方向：中药复方 经验分享：问下大家，你们当时投稿decision panding这个状态多久呢？最终结果怎么样？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr.Ding Jin, createdTime=Fri Apr 22 15:28:26 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172861, encodeId=2ca821e2861ec, content=一年零一个月了。。。终于接收，历经无数次小修。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Mon Dec 04 14:10:25 CST 2023, time=2023-12-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198639, encodeId=8f90219863982, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：成分鉴定;中药复方 经验分享：12月9号投的稿，一月底送审的，第一次送审还挺快，一个月左右意见就返回来了，小修一下。然后2.28返修提交，到现在4月中旬了还在外审，催了后回信也没有什么有用的消息。得等到什么时候去呀，太慢了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2e98540760, createdName=ms1000002137683196, createdTime=Mon Apr 15 17:12:13 CST 2024, time=2024-04-15, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2192146, encodeId=fa3521921467f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药理实验;中药复方 经验分享：目前已经一轮大修一轮小修，正在等第三次送审的结果，着急毕业，希望顺顺利利直接接收！！ 先提前谢过心软的编辑和审稿人！ SUBMISSION 21 November 2023 Submission Created 24 November 2023 Submission Incomplete 24 November 2023 Manuscript Submitted 24 November 2023 With Journal Administrator 25 November 2023 Submission Returned to Author 01 December 2023 Submission Incomplete 01 December 2023 Manuscript Resubmitted 01 December 2023 With Journal Administrator PEER REVIEW 09 December 2023 With Editor 11 January 2024 Out for Review 11 January 2024 Revision Required 20 January 2024 Revision Incomplete 20 January 2024 Revised Manuscript Submitted 20 January 2024 With Journal Administrator 23 January 2024 With Editor 24 January 2024 Out for Review 25 February 2024 Revision Required 28 February 2024 Revision Incomplete 28 February 2024 Revised Manuscript Submitted 28 February 2024 With Journal Administrator 29 February 2024 With Editor 01 March 2024 Out for Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9c95613916, createdName=ms8000001918173079, createdTime=Fri Mar 08 18:16:30 CST 2024, time=2024-03-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2196871, encodeId=1fda21968e151, content=审稿速度:12.0 | 投稿命中率:5.0 经验分享：个人在这个杂志的投稿经历，一审二审周期都两个月以上，审稿进度极其慢。邀请的审稿人很垃圾，让添加他的文章作参考文献。杂志对格式，细节审查要求极高，近乎苛刻。最后，可能在漫长的两三轮审稿后，主编以莫名奇妙的理由拒稿。建议不到万不得已，各位研究生不要投稿这个杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIPEgUxy7bkaMic6PO4Jdb2frmicGajQicFzHXDaskTsWkcsiab2CLfmeiaLj2wsJFfJz7Phcwe2HYVREQ/132, createdBy=f701107915, createdName=ms898308530249, createdTime=Thu Apr 04 00:20:11 CST 2024, time=2024-04-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=855246, encodeId=3dac8552467b, content=感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ec45414146, createdName=ms3214948925389860, createdTime=Mon Nov 25 12:59:13 CST 2019, time=2019-11-25, status=1, ipAttribution=)]

2019-11-25 ms3214948925389860

感觉好扎心，一周就送审了，后边2个月没消息。。结果被告知审稿人失联了，让我继续等。。。又等了一个月，催稿，直接被拒。。。审稿人意见比较中肯，有三个很小的问题，但是编辑却很强硬，各种说我语言和格式问题。。。我。。无语。。。想拒稿不要送外审啊！！三个月啊！！！！

145 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务